Safety of Hormone Replacement Therapy for Premature Surgical Menopause
Benefits of HRT in Premature Surgical Menopause
- HRT minimizes the long-term consequences of early menopause, including increased risks of cardiovascular disease, osteoporosis, cognitive dysfunction, and early mortality 1, 2
- HRT provides relief from immediate menopausal symptoms such as vasomotor symptoms, mood changes, sleep disturbance, vaginal dryness, and sexual dysfunction 1, 3
- HRT should be initiated immediately after BSO to maximize benefits and minimize symptom development 1
Safety Considerations and Recommendations
Timing and Duration
Formulation Considerations
- For women without hysterectomy, estrogen must be used with progestogen to protect against endometrial cancer 1
- For women who have undergone hysterectomy, estrogen-only therapy is appropriate and may have a more favorable safety profile 2
- Progestogen can be delivered via an intrauterine system, which has fewer adverse effects than systemic progestogen 1
Risk Assessment
- HRT is contraindicated in women with a personal history of breast cancer or venous thromboembolism 1
Special Populations
Genetic Risk Considerations
- For women with Lynch syndrome (LS), estrogen replacement therapy should be considered following BSO to prevent detriments to bone health, cardiovascular health, and quality of life 5, 6, 7
- The timing of BSO and subsequent HRT should be individualized based on the specific genetic variant, as cancer risks vary by gene 5, 8
Common Pitfalls and Concerns
- Estrogen replacement therapy should be considered even in women with moderate breast cancer risk if they are younger than the age of expected natural menopause 1